Business Description
Intelligent Bio Solutions Inc
NAICS : 423450
SIC : 5047
ISIN : US36151G6008
Share Class Description:
INBS: Ordinary SharesTotal Employee Number:
55Description
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.71 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.04 | |||||
Beneish M-Score | -2.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 76.6 | |||||
3-Year EPS without NRI Growth Rate | 75.7 | |||||
3-Year FCF Growth Rate | 68.9 | |||||
3-Year Book Growth Rate | -84.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.7 | |||||
9-Day RSI | 41.37 | |||||
14-Day RSI | 41.22 | |||||
3-1 Month Momentum % | -20.51 | |||||
6-1 Month Momentum % | -73.98 | |||||
12-1 Month Momentum % | -85.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.11 | |||||
Quick Ratio | 1.99 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 110.75 | |||||
Days Sales Outstanding | 58.92 | |||||
Days Payable | 499.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -396 | |||||
Shareholder Yield % | -51.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 47.24 | |||||
Operating Margin % | -284.65 | |||||
Net Margin % | -296.73 | |||||
EBITDA Margin % | -264.92 | |||||
FCF Margin % | -283.11 | |||||
OCF Margin % | -279.92 | |||||
ROE % | -182.69 | |||||
ROA % | -96.16 | |||||
ROIC % | -138.66 | |||||
3-Year ROIIC % | -80.99 | |||||
ROC (Joel Greenblatt) % | -780.55 | |||||
ROCE % | -161.87 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 8.35 | |||||
PS Ratio | 0.56 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.75 | |||||
EV-to-EBIT | -0.01 | |||||
EV-to-EBITDA | -0.01 | |||||
EV-to-Revenue | 0.03 | |||||
EV-to-FCF | -0.01 | |||||
Price-to-GF-Value | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.16 | |||||
| Price-to-Net-Cash | 4.65 | |||||
Earnings Yield (Greenblatt) % | -10000 | |||||
FCF Yield % | -207.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INBS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intelligent Bio Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.914 | ||
| EPS (TTM) ($) | -12.2 | ||
| Beta | 4.2778 | ||
| 3-Year Sharpe Ratio | -0.65 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 84.32 | ||
| 14-Day RSI | 41.22 | ||
| 14-Day ATR ($) | 0.188909 | ||
| 20-Day SMA ($) | 2.32525 | ||
| 12-1 Month Momentum % | -85.24 | ||
| 52-Week Range ($) | 2.08 - 24.9 | ||
| Shares Outstanding (Mil) | 2.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intelligent Bio Solutions Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intelligent Bio Solutions Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings results for 2027 | 2026-11-12 | In 133 days | ||
| Annual report for 2026 | 2026-08-14 | In 43 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-14 | In 43 days | ||
| General meeting for 2025 | 2026-07-03 15:30 | In 2 days | ||
| Third quarter earnings results for 2026 | 2026-05-13 | 3.18 (+0.95%) | ||
| Second quarter earnings results for 2026 | 2026-02-12 | 5.25 (-5.41%) | ||
| 0.1:1 Stock Split | 2025-12-16 | 5.50 (+2.23%) | ||
| Guidance call for 2025 | 2025-12-03 11:00 | 6.61 (+1.62%) | ||
| First quarter earnings results for 2026 | 2025-11-12 | 8.07 (+0.36%) | ||
| Annual report for 2025 | 2025-08-15 | 14.80 (-1.99%) |
Show
Entries
Intelligent Bio Solutions Inc Frequently Asked Questions
What is Intelligent Bio Solutions Inc(INBS)'s stock price today?
The current price of INBS is $2.23. The 52 week high of INBS is $24.90 and 52 week low is $2.08.
When is next earnings date of Intelligent Bio Solutions Inc(INBS)?
The next earnings date of Intelligent Bio Solutions Inc(INBS) is 2026-08-14 Est..
Does Intelligent Bio Solutions Inc(INBS) pay dividends? If so, how much?
Intelligent Bio Solutions Inc(INBS) does not pay dividend.
Guru Commentaries on NAS:INBS
No articles.
Articles on Intelligent Bio Solutions Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers